Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US

Go back to Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US
Hikma Pharmaceuticals plc, London Sponsored ADR (AMEX: HKMPY) Delayed: 44.60 -0.76 (1.68%)
Previous Close $45.36    52 Week High $76.47 
Open $44.60    52 Week Low $50.73 
Day High $44.60    P/E N/A 
Day Low $44.60    EPS $0.00 
Volume 349